Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 49
Gulf War and Health, Volume 6: Physiologic, Psychologic, and Psychosocial Effects of Deployment-Related Stress 4 THE STRESS RESPONSE In considering whether being deployed to a war zone may result in long-term health effects in veterans, it is important to ask whether the stressors experienced by the veterans during their deployment could produce the stress response. If they could, might that response lead to physiologic changes that could eventually be manifested as long-term health effects? Those questions address the issue of biologic plausibility as discussed in Chapter 2: Are there biologic mechanisms by which exposure to deployment-related stress could lead to adverse health effects? This chapter explores the research being done on why and how people and animals respond to stress. It describes the stress response, including its basic biology and physiology, and its modifiers. The chapter also surveys some of the potential adverse consequences of the stress response that can occur in organ systems after exposure to chronic stressors. The implications of the stress response for long-term health effects in humans are described in Chapters 6 and 7. The word stress is used in many contexts and has a variety of meanings. It is often used to describe a situation characterized by real or perceived threats to a person, but it is also commonly used to refer to the body’s response to such threats. Thus, stress has been used both to describe the environmental events (the stressors) that trigger responses and to refer to the resulting changes (stress responses) that occur in the brain and the rest of the body. The stress response enables humans and other organisms to survive unsafe and life-threatening conditions through “fight or flight,” as the response is widely called. As described below, it is a cascade of physiologic changes that is activated rapidly in emergencies. Some of the changes occur immediately, within minutes to hours; others emerge after days to weeks (Box 4-1), depending on the stressor’s severity. The repertoire of responses is similar across human cultures and other species. One of the earliest steps in the stress response is the brain’s perception that an event is threatening, which determines how an organism responds physiologically, emotionally, and behaviorally to the stressor. Possible responses include aggression, escape, anxiety, and executive function (a complex set of behaviors). The response to the stressor—for example, the sound of a gun—is dictated by the split-second appraisal of whether it poses a genuine threat. A feature that is most refined in humans is the capacity to learn from stressful experiences, to think abstractly, and to draw on lessons when coping with harm in the future (McEwen and Lasley 2002). The lessons learned are often etched into the brain through measurable structural and functional alterations in nerve cells and networks. Human stressors are not only external; they can be internal, such as worry, guilt, or rumination about past or future events. Internal and external stressors both contribute to allostatic overload, a concept for explaining in physiologic terms the effects of chronic or cumulative stress (McEwen 2007).
OCR for page 50
Gulf War and Health, Volume 6: Physiologic, Psychologic, and Psychosocial Effects of Deployment-Related Stress BOX 4-1 Physiologic Changes During the Stress Response Early Phase of the Stress Response (Duration: Minutes to Hours) Increased heart rate and blood pressure Increased respiration Mobilization of energy from liver and body fat Sharpening of attention and cognition Increased fear conditioning (learning) Blunting of pain Altered intestinal motility Later Phases of the Stress Response (Duration: Days to Weeks) Enhanced immune system Suppression of appetite and digestion Suppression of growth Suppression of reproduction Persistence of increased heart rate and blood pressure in some cases Persistence of increased cortisol in some cases Release of stress hormones When a stressor is eliminated, the stress response may shut off quite slowly or not at all (McEwen and Lasley 2002). It is the long-term activation of the stress response—long after the threat has ceased—that poses the greatest risk to human health. Paradoxically, the human stress response is life-saving in the short term (and is adaptive) when immediate stressors are confronted, but it can lead to illness or disease when stressors are severe, recurrent, or persistent in the long term (and is maladaptive). Although many veterans consider deployment, particularly combat, to be highly stressful and even traumatic, there are many periods during deployment when stressors are not traumatic but are severe and persistent (for example, separation from family and worry about home or work). Prolonged exposure to such stressors, whether in military or civilian life, can overwhelm otherwise healthy people and can lead to health-damaging behaviors, such as smoking and excessive drinking, in an attempt to alleviate the stress. CENTRAL ROLE OF THE BRAIN Once the brain interprets a situation as threatening, it assumes immediate control over the endocrine, cardiovascular, immune, and digestive system. The brain relies on an elaborate communication network that includes hormones, neurotransmitters, chemicals associated with the immune system, and other molecular signals. This section discusses the various regions of the brain involved in the body’s response to stress, the effects of the brain on other organ systems that play roles in the stress response, and the feedback mechanisms that occur in response to acute and chronic stress. The stress response is spearheaded by the hypothalamus-pituitary-adrenal (HPA) axis in the peripheral stress-response pathway and by the sympathetic nervous system in the central
OCR for page 51
Gulf War and Health, Volume 6: Physiologic, Psychologic, and Psychosocial Effects of Deployment-Related Stress stress-response pathway. The sympathetic system activates internal organs (such as heart, lungs, and liver) and mobilizes energy to respond to stressors. The parasympathetic nervous system does the opposite, preserving energy, putting a brake on the heart rate, increasing intestinal activity, relaxing muscles in the gastrointestinal system, and decreasing inflammation. Those functions have earned the parasympathetic system the nickname “rest and digest,” compared with the “fight or flight” of the sympathetic system. The stress response is adaptive (it promotes survival), but it is maladaptive if it is chronically activated over a long time. Long-term activation of the stress response can cause abnormalities in the brain or in other parts of the body. Reticular Activating System In response to any stimulus, including stimuli that are novel or potentially threatening, a primary brain system that is activated is the reticular activating system (RAS). Without activation of the RAS there would be no stress response or waking behavior; indeed, loss of RAS function results in a persistent vegetative state. The RAS works closely with the cholinergic, noradrenergic, and serotonergic systems of the brainstem and influences other brain areas, such as the cerebral cortex, hypothalamus, amygdala, and cerebellum. Novel and potentially threatening stimuli, such as a loud sound, induce a massive output from the RAS that does three things: it activates the pontine reticular formation to potentiate the startle response, which is part of a general protective system (the eyes close, flexion in humans lowers the head from danger, and muscles tighten in preparation for attack from an enemy); it activates the thalamus to trigger synchronization of fast rhythms between the thalamus and cortex that “awaken” the cortex, placing it in a “ready” position; and it participates with forebrain structures in activating the hypothalamus to trigger the HPA axis and the surge of epinephrine from the adrenal medulla. The “fight or flight” response is therefore a brainwide and bodywide response to novelty and threat that involves activation of the RAS with other coordinated brain systems. The RAS is dysregulated in anxiety disorders and depression. In fact, some of the first symptoms of posttraumatic stress disorder (PTSD) and depression are sleep-wake problems (see Chapter 5). Both disorders are marked by increased vigilance and increased REM-sleep drive, which can result in vivid dreaming and REM-sleep intrusion into waking, for example, hallucinations (Pfaff 2005). In some cases, the RAS can be activated directly by inputs to the brainstem from the periphery, such as a loud sound, pain, touch, or signals from the gut via the vagus nerve. For the other senses, the sensory information reaches the RAS via the amygdala, which also can respond directly to a stimulus, such as a loud sound, pain, or touch. Importance of the Amygdala The stress response begins with sensory information about a stressor—its visual images, sounds, smells, touch, or other sensations (Figure 4-1). Information from sensory nerve cells in peripheral tissues is relayed to several regions of the brain, including the hypothalamus, thalamus, somatosensory cortex, nucleus of the solitary tract, ventral lateral medulla, and the parabrachial nucleus and insular cortex. Each of those regions sends signals to the amygdala (in the temporal lobes of the cerebrum) which integrates all the incoming sensory signals (Bonne et al. 2004) and to the hypothalamus. The amygdala consists of collections of cell types (nuclei) that form the “extended amygdala.” The extended amygdala consists of the central and basolateral nucleus of the amygdala, and the lateral bed nucleus of the stria terminalis (BNST) (Alheid and Heimer 1988; Davis and Whalen 2001). The BNST also receives input from the
OCR for page 52
Gulf War and Health, Volume 6: Physiologic, Psychologic, and Psychosocial Effects of Deployment-Related Stress hippocampus (a part of the brain in the medial temporal lobe). Both the central nucleus of the amygdala and the lateral BNST, when activated, transmit impulses to several other regions of the brain, including the locus coeruleus, which uses norepinephrine (also called noradrenalin) to send signals to numerous other parts of the brain. Several parts of the hypothalamus and many of the same brainstem nuclei activate the sympathetic nervous system, which with the locus coeruleus forms part of the “central stress response,” preparing for fight or flight. The hypothalamus is especially important for regulating the sympathetic nervous system because it receives sensory input from virtually the entire body, including the amygdala and BNST. FIGURE 4-1 Stress-response pathways. NOTE: ACTH = adrenocorticotrophic hormone, CRH = corticotropin-releasing hormone, RAS = reticular activating system. The sympathetic nervous system uses epinephrine to stimulate the inner region of the adrenal gland to secrete large amounts of epinephrine and other catecholamines1 into the circulation. The surge of epinephrine floods the brain and peripheral tissues, thereby producing the full-fledged fight or flight response: faster heartbeat, greater energy, more blood flow to skeletal and cardiac muscle, dilation of the pupils and airways, and higher blood glucose concentration and so on. With chronic stress, however, the sympathetic nervous system may 1 Catecholamines are a class of hormones and neurotransmitters that includes epinephrine and dopamine.
OCR for page 53
Gulf War and Health, Volume 6: Physiologic, Psychologic, and Psychosocial Effects of Deployment-Related Stress remain reactive and produce catecholamines for many years. That is commonly seen in people with anxiety disorders who have increased heart rates and blood pressure. Long-term increase in catecholamines can produce chronic inflammation, as discussed later in the chapter. The Hypothalamus-Pituitary-Adrenal Axis In the peripheral stress pathway, the hypothalamus secretes corticotropin-releasing hormone (CRH), which acts on the pituitary to secrete corticotropin (also known as adrenocorticotropic hormone). Corticotropin enters the bloodstream and acts on the adrenal cortex to induce release of the glucocorticoid hormone cortisol. This pathway is known as the HPA axis or peripheral stress response (Chrousos and Gold 1992; Selye 1956). Cortisol is distributed to body tissues where it serves several functions, such as replenishing energy lost to the epinephrine surge, increasing cardiovascular tone; enhancing memory for avoiding danger in the future; preserving energy; and, if necessary, activating immune-cell migration to areas of the body where there is infection or injury (McEwen and Lasley 2002). Cortisol also has key functions in the brain: it acts to increase arousal, vigilance, attention, and formation of memories (Charney 2004). It can also act in the amygdala and BNST to increase production and release of CRH from the hypothalamus. Cortisol also facilitates fear conditioning (Roozendaal et al. 2006). However, if the cortisol surge is large and prolonged, it can suppress growth, tissue repair, reproduction, digestion, and inflammation (Sapolsky 2003). When cortisol reaches the brain it exerts a negative feedback on the HPA axis. First, it binds to glucocorticoid receptors in the hippocampus (McEwen et al. 1968), which projects into the hypothalamus, and binds to glucocorticoid receptors in the hypothalamus. Cortisol binding in both the hippocampus and the hypothalamus acts to turn off CRH production and release by the hypothalamus (Herman et al. 1989; McEwen et al. 1992). The net effect is that high cortisol concentrations reaching the brain inhibit the HPA axis (McEwen 2002b; Vermetten and Bremner 2002). Thus, glucocorticoids, such as cortisol, enhance CRH in the amygdala and help to turn on the HPA axis when activated by stress, and a feedback mechanism turns the HPA axis off at the level of the hypothalamus and pituitary (see Figure 4-1). It is the balance between activation via the amygdala and inhibition via the hypothalamus, prefrontal cortex, and hippocampus that determines HPA activity and how rapidly it is turned on and off. The hippocampus plays a key role in shaping memories; it forms explicit memory, which is the ability to recollect an event consciously and to assemble its pieces to form a coherent memory of the whole event. The opposite, nondeclarative memory, refers to memories not consciously recalled, for example, such skills as playing the piano and reading. For fearful memories, the hippocampus works with the amygdala and the prefrontal cortex of the brain. The prefrontal cortex modulates the actions of the amygdala, usually through inhibition, and thus can control cortisol secretion and activation of the parasympathetic and sympathetic nervous systems (Radley et al. 2006; Thayer and Brosschot 2005). The prefrontal cortex also participates in attention, decision making and sense of control, working memory, extinction of fear memories, and other aspects of cognitive flexibility (Hariri et al. 2006; McDougall et al. 2004). The effects of cortisol (peripheral pathway) and epinephrine (central pathway) are not restricted to the central nervous system (CNS). Many other tissues respond to cortisol and communicate with the CNS in a bidirectional manner. Of particular concern for the stress response is the immune system. In the acute phase of the stress response, the immune system fights infection and repairs wounds by boosting immunity. Some immune cells (such as leukocytes, white blood cells) are rapidly deployed from the circulation to the skin, where they
OCR for page 54
Gulf War and Health, Volume 6: Physiologic, Psychologic, and Psychosocial Effects of Deployment-Related Stress protect wounds against viruses, bacteria, and fungi. They are summoned there by cytokines, which are released at the wound site (Dhabhar 2000). Cytokines are small proteins that are secreted most typically by immune cells and signal or activate other immune cells. Functioning somewhat as hormones do, they regulate the immune response to infection and injury. The communication link between the HPA axis and the immune system is strong: lymphocytes and macrophages (types of white blood cells) have receptors for cortisol, and some immune-related cells in the brain have receptors for cytokines (Reiche et al. 2004) and are activated by cortisol. In response to chronic stress, a long-term increase of glucocorticoids, such as cortisol, can dysregulate and suppress immune function, as discussed later. Allostasis The classic fight or flight response entails activation of epinephrine and cortisol with resulting increases in immune function, energy mobilization (in the form of glucose), and enhancement of memory, which helps to avoid the threat in the future. To maintain homeostasis, the brain regulates the stress response by inducing the body to release chemical mediators—including neurotransmitters, immune-system messengers, and hormones, including cortisol and epinephrine, a process called allostasis (McEwen 1998, 2005, 2007; McEwen and Wingfield 2003). Homeostasis refers to stability in various physiologic characteristics, such as body temperature, pH, and oxygen tension, which are tightly regulated within narrow ranges that promote survival. The chemical mediators of allostasis are released from the sympathetic and parasympathetic branches of the nervous system but are also released from the immune, cardiovascular, and metabolic systems. Their interactions occur through a nonlinear network, that is, mediators from each system regulate the production of others in a series of checks and balances. Corresponding to multiple mediators of the stress response, there are multiple pathways by which they regulate it. In the sympathetic system, for example, greater activity of proinflammatory cytokines, signaling molecules used by the immune system, elicits greater activity of anti-inflammatory cytokines—that is, negative feedback—and negative regulation by the parasympathetic and glucocorticoid pathways. Parasympathetic activity working through the acetylcholine receptors on immune cells reduces production of proinflammatory cytokines (Tracey 2002). In other words, as the activity of proinflammatory cytokines increases, other systems can produce the opposing activity. That example shows how homeostasis can be achieved through numerous routes using a common set of interacting mediators (McEwen 2007). Allostatic Load and Overload Allostatic load refers to the burden of chronic stress and altered personal behaviors (“lifestyle”) that results from effects of overuse and dysregulation of the mediators of allostasis (Figure 4-2; McEwen 1998). Allostatic load is often manifested by fatigue, anger, frustration, and feeling out of control. Those feelings can lead to sleep loss (McEwen 2006, 2007), anxiety,
OCR for page 55
Gulf War and Health, Volume 6: Physiologic, Psychologic, and Psychosocial Effects of Deployment-Related Stress FIGURE 4-2 How chronic stress can affect behavior and health. All people have some pre-existing load of stressful experiences reflected in brain and body. Chronic life stressors (such as interpersonal conflicts, care-giving, pressure at work, and crowded and noisy living and working conditions) can affect people by creating a sense of chaos, conflict, and a lack of control. The result of the chronic stressors will often be chronic anxiety and depressed mood with poor-quality sleep. Anxiety, mood changes, and inadequate sleep can lead to self-medication through eating “comfort foods,” excessive alcohol drinking, smoking, and neglecting regular exercise. Together with the anxiety, depressed mood, and poor sleep, these behaviors dysregulate the normal physiological activities and create a chronic stress burden (allostatic overload). The dysregulated stress response involves increased cortisol, insulin, and inflammatory cytokines at night; along with increased heart rate and blood pressure; and reduced parasympathetic tone. If this abnormal dysregulated state persists for months and years, there are likely to be adverse health outcomes, such as hypertension, coronary heart disease, stroke, obesity, diabetes, arthritis, major depression, gastrointestinal disorders, chronic pain, and chronic fatigue. depression, and such health-damaging behaviors as overeating (Dallman et al. 2003), smoking, and excessive drinking (Anda et al. 1990; Dube et al. 2002). Those behaviors, in turn, increase and dysregulate the body’s mediators normally involved in allostasis. When one mediator, such
OCR for page 56
Gulf War and Health, Volume 6: Physiologic, Psychologic, and Psychosocial Effects of Deployment-Related Stress as cortisol, is present in excessive or insufficient amounts, other mediators are also changed. Over the course of days, weeks, and longer, allostatic load eventually can disrupt health, a condition called allostatic overload or toxic chronic stress response. Allostatic overload is maladaptive: it serves no useful purpose and predisposes the body to disease. Allostatic load and allostatic overload are points on a continuum. The pattern, frequency, and duration of stressors are important determinants of the severity of the outcome, as are a person’s response to the stressors. Four types of physiologic responses lead to allostatic load and overload (Figure 4-3). Two of them are related to individual differences in the stress response: prolonged response (B) and inadequate response (C). The other two are related to chronic stressor characteristics: repeated exposure (D in the figure) and lack of adaptation (E). Initially, the health consequences of allostatic load or overload are early indicators of possible later disease, such as hypertension, obesity, increased cholesterol, bone mineral loss, muscle protein loss, memory impairment, and increased anxiety. MODIFIERS OF THE STRESS RESPONSE Many factors may alter a person’s response to stress, including genetic makeup, early-life history, and the degree to which the stressor can be controlled. Research is under way on all those, primarily in animal models. Each is discussed below. Genes Many aspects of the stress response—such as learned and innate fear (see, for example, Shumyatsky et al. 2005), reward, social behavior, and resilience (Charney 2004)—are likely to be under the influence of particular genes. Genes determine which proteins will be made and where they will be made. The same gene might have slightly different sequences (alleles) that alter the protein production. An example of allelic variation occurs in the gene that codes for the serotonin-transporter protein. That protein removes serotonin—a chemical messenger in the brain that affects emotions, mood, behavior, and thought—from the synaptic cleft between nerve cells after it is released by a presynaptic cell. A short allele makes less of this protein than the long allele found in most people, thus altering serotonin transmission (Hariri et al. 2006). In some studies, people with the short allele are prone to more anxiety and more likely to acquire conditioned fear responses (Hariri et al. 2006). Furthermore, they are more likely to develop depression but only if they were maltreated in childhood (Caspi et al. 2002). Thus, just having the short allele does not necessarily lead to depression, but combined with early life stress it can increase the risk of depression. Conversely, people with the longer allele (and higher levels of serotonin transporter) were less likely to develop depression even if they had been maltreated in childhood; the longer allele protected them. That is an example of gene-environment interactions in which a medical condition cannot be predicted only by a gene or only by a serious life event but requires a combination of a genetic factor and an environmental event for the outcome to occur. Researchers have investigated the mechanisms that might explain such gene-environment interactions. For example, Ichise et al. (2006) examined the same interactions between a short serotonin-transporter allele and exposure to early-life stress in rhesus monkeys. Monkeys reared by peers rather than by their mothers—a stressful condition—showed a decrease in serotonin
OCR for page 57
Gulf War and Health, Volume 6: Physiologic, Psychologic, and Psychosocial Effects of Deployment-Related Stress FIGURE 4-3 Chronicity of stressors. Top panel (A) shows a normal stress response that is turned on by the stressor and shut off when the stressor is terminated. Individual stress responses may be prolonged (B) or inadequate for the situation (C). The repetition of stressful events (D) and lack of adaptation to similar stressors (E) can lead to toxic stress and a chronic stress burden. SOURCE: Adapted with permission from McEwen (1998). binding in several regions of the brain involved in the stress response (for example, the amygdala, hypothalamus, hippocampus, and raphe nucleus). The authors suggested that early-life stress affects the development of the serotonin system and that it might account for some of the behavioral abnormalities—including greater alcohol consumption, aggressiveness, and impaired
OCR for page 58
Gulf War and Health, Volume 6: Physiologic, Psychologic, and Psychosocial Effects of Deployment-Related Stress impulse control—seen in the peer-reared monkeys (Barr et al. 2004). Such studies may elucidate the neural circuits governing the stress response and how they interact with the environment and on some of the variation in response to stress. Early-Life Stress In the 1950s, Harlow found that lack of maternal care and handling is a severe form of early-life stress. Rhesus monkeys that had been “raised” by artificial mothers (made of bare wires) were stricken with terror when they were placed in novel situations (Harlow 1974), and those raised by their peers showed more anxiety and hyperarousal than monkeys raised by their biologic mothers (Mineka and Suomi 1978). Early-life stress has been associated with increases in cortisol and other markers of increased HPA-axis activity (Levine 1962). In rats, normal maternal handling during infancy leads to a life-long increase in the number of glucocorticoid receptors in the hippocampus, whereas a lack of maternal handling decreases the number of glucocorticoid receptors in the stressed animals, and the decreases persist into adulthood and old age (Meaney et al. 1985, 1988). A greater density of glucocorticoid receptors after normal handling would be expected to increase negative feedback between the hippocampus and the HPA (see Figure 4-1) and result in greater inhibition of the HPA axis after a stressful event, which in turn would lead to a less reactive HPA axis, lower cortisol concentrations, and more rapid initiation of the stress response. But the lower density of receptors in the heavily stressed offspring would be expected to reduce negative feedback and lead to greater reactivity of the HPA axis, higher cortisol concentrations, and more prolonged stress response. Higher cortisol concentrations, which persisted from youth through old age, were indeed found in nonhandled (stressed) animals. At greater ages, the excess secretion of cortisol was associated with structural changes in the hippocampus and with deficits in spatial memory (Meaney et al. 1988). Normal maternal care led to lower concentrations of corticotropin and cortisol, indications of a less reactive HPA axis (Liu et al. 1997; Meaney et al. 1985; Sapolsky et al. 1986). Evidence that early-life stress results in an overreactive HPA axis has come also from studies of CRH. As described earlier, CRH is released by the hypothalamus under the regulatory influence of the hippocampus, prefrontal cortex, and amygdala, and it signals the pituitary gland to release corticotropin, which leads to a release of cortisol by the adrenal gland (see Figure 4-1). Primates reared under conditions of early-life stress (unpredictable conditions for the mother to find food) displayed persistent increases of CRH throughout adulthood (Coplan et al. 1996). The timing of exposure to the stressor was important: CRH decreased when the stressful condition occurred later in infancy (Mathew et al. 2002). Those studies have helped to establish that early-life stress has permanent effects on the regulation of the HPA axis. Human studies have demonstrated associations that appear to be consistent with the findings on early-life stress in animal studies. In a study of the effects of childhood abuse in New Zealanders followed from birth until their 30s, an association was found between childhood abuse and chronic inflammation in adulthood. The inflammatory marker C-reactive protein—a better marker for myocardial infarction than cholesterol concentrations—was found to be above normal in many of the young adults known to have been abused. A dose-response relationship was seen between the level of abuse and the concentration of C-reactive protein (Danese et al. 2007).
OCR for page 59
Gulf War and Health, Volume 6: Physiologic, Psychologic, and Psychosocial Effects of Deployment-Related Stress Controllability One important modifier of the stress response is the degree to which a stressor is perceived as controllable (Maier and Watkins 2005). Animal studies have indicated that a sense of control is an important aspect of hardiness. Experiments have shown that animals with control over the amount of shock they received fared much better those deprived of control (Maier et al. 1969; Seligman and Maier 1967; Weiss 1968). Rats that lacked control of the shock they received ate less, lost more weight, developed more ulcers, had higher resting blood pressure and higher plasma cortisol, displayed less aggression in the face of an intruder, were less responsive on standard measures of pain sensitivity and reactivity, and had more immunosuppression (Maier and Watkins 1998); they also had changes in epinephrine in the locus coeruleus and hypothalamus (Weiss et al. 1981). Similar experiments in dogs (Chourbaji et al. 2005; Overmier and Seligman 1967; Vollmayr and Henn 2001) found that those given inescapable shocks failed to avoid later shocks even when they were able to, a behavior called learned helplessness. The biologic mechanism that underlies how uncontrollable stress might lead to deficits in escape appears to be abnormal activation of two brainstem nuclei: the dorsal raphe nucleus and the locus coeruleus (Maier et al. 1995). Activation of neurons there leads to the release of the neurotransmitters serotonin and norepinephrine into almost all parts of the brain, where they modify cellular activity. However, the mechanism by which those primitive brainstem nuclei mediate the complex cognitive process required to judge the uncontrollability of a stressor has been unclear. It has recently been shown in rats that stress always activates the brainstem nuclei, but activation is inhibited by the prefrontal cortex, a brain structure that appears to be dysregulated in people with PTSD (see Chapter 5) (Amat et al. 2005). Thus, a dysfunctional prefrontal cortex in PTSD could perhaps exacerbate a feeling of being out of control. Animal studies illustrate the potential role of perception of control in the stress-response process. CHRONIC STRESS AND HEALTH Activation of the stress response ensures survival in the short term, but is maladaptive when its activation persists as a result of chronic, severe, or repeated stress. Chronic stress can lead to adverse health outcomes that affect multiple body systems such as the CNS and the endocrine, immune, gastrointestinal, and cardiovascular systems. Stress-induced abnormalities are due to dysregulation of a common set of mediators: cortisol, epinephrine, and immune-system cytokines. The model of stress-related illness is built on evidence of interrelationships between stress hormones and other systems, including the endocrine and immune systems. Stress hormones can trigger interactions between the endocrine and immune systems that culminate in a state of chronic inflammation. Stress-induced chronic inflammation appears to be a driving force behind wide-ranging conditions linked to stress, such as obesity, heart disease, diabetes, and chronic pain (Black and Garbutt 2002; Black et al. 2006; Malarkey and Mills 2007). Research on the role of inflammation with the CNS is focusing on interrelationships between immune cells, cytokines, and nearby neurons situated in regions of the brain implicated in stress-related disorders (MacPherson et al. 2005). This section reviews some of those adverse health effects; in many cases, they are markers of disease or symptoms rather than specific diseases.
OCR for page 64
Gulf War and Health, Volume 6: Physiologic, Psychologic, and Psychosocial Effects of Deployment-Related Stress grade inflammatory processes that set in motion the pathologic changes that lead to cardiovascular disease (Black and Garbutt 2002; Black et al. 2006). That hypothesis draws from evidence that during the acute stress response, cortisol, catecholamines, angiotensin, and other stress hormones induce the liver and abdominal fat tissue to release proinflammatory cytokines and other inflammatory mediators. Inflammatory molecules, when increased for a long time, lead to a chronic state of inflammation, especially in abdominal fat and vasculature, which contribute to insulin resistance. Inflammation in the vasculature is manifested by recruitment and adherence of white blood cells to the vascular lining and their migration to the inner portions of the lining, binding of receptors to LDL particles, and growth of fibrous tissue. Those processes set the stage for plaque development (Libby 2002). A key marker of the inflammatory process in the circulatory system is C-reactive protein, an independent predictor of cardiovascular risk (Kardys et al. 2006; Libby 2002). In a prospective study, older adults who were current or former caregivers for Alzheimer’s disease patients and harbored chronic hostility or pain had more inflammation, as measured by C-reactive protein, when other risk factors were accounted for, than did noncaregiver controls (Graham et al. 2006). Gastrointestinal System and Brain-Gut Axis Research is advancing our understanding of the interaction between stress and emotional trauma and the effects on the brain-gut axis, particularly with respect to irritable bowel syndrome (IBS) and other functional gastrointestinal disorders, such as functional dyspepsia (Dilley et al. 2005; Drossman 2005; Longstreth et al. 2006). IBS is the most common gastrointestinal condition seen in primary-care or gastroenterology practice; it is clinically manifested by symptoms of abdominal pain and altered bowel habit (for example, diarrhea, constipation, or both). Those symptoms are produced and amplified by gut-related stressors (such as eating, physical activity, and hormonal changes) or by other stressors, such as abuse, a history of trauma, or psychosocial comorbidities. The stressors appear to disrupt the brain-gut neurophysiologic regulatory pathways that alter intestinal motility and visceral sensation thresholds either centrally or peripherally. Figure 4-4 shows the relative prevalence of IBS according to severity and shows the relative contributions of peripheral and psychosocial factors to severity. In effect, more severe psychosocial disturbance, including abuse and war trauma, leads to greater symptom reporting, poorer health status, greater psychologic comorbidity, and poorer quality of life. Several lines of evidence support the concept of dysregulation of stress circuitry in IBS that is linked to and affects gut function (and vice versa). The evidence includes altered CRH and corticotropin reactivity to stress and an increased gut response (motility and pain) to CRH (Dinan et al. 2006; Fukudo et al. 1998; Sagami et al. 2004; Tache et al. 2005) which can be blocked by CRH antagonists (Sagami et al. 2004); increased mucosal inflammatory activity (Chadwick et al. 2002); stress-caused loss of the integrity of the intestinal mucosal barrier to bacterial pathogens and other toxins, which in turn causes entry or release of toxic substances that lead to inflammation and nerve sensitivity (Barbara et al. 2006, 2007; Soderholm et al. 2002; Yang et al. 2006); and altered brain regulation of incoming visceral pain signals leading to an increased pain experience that is enhanced by stress (Chang et al. 2003; Drossman et al. 2003; Naliboff et al. 2001; Ringel et al. 2003a,b). There is also evidence that the mediating mechanisms of reduction in pain can be evaluated with brain imaging (Drossman et al. 2003).
OCR for page 65
Gulf War and Health, Volume 6: Physiologic, Psychologic, and Psychosocial Effects of Deployment-Related Stress FIGURE 4-4 The brain-gut axis and IBS. Relative prevalence of IBS according to severity, and relative contributions of peripheral (left side of triangle) and psychosocial (right side of triangle) factors to severity. Most patients have mild to moderate IBS symptoms with increased peripheral-nerve signaling. However, a smaller group of patients with moderate to severe symptoms also have impaired modulation of pain at the CNS level, which is enabled by psychosocial factors (such as trauma, abuse, life stress, psychosocial comorbidities, and poor coping). These patients experience increased symptoms at the level of the CNS signaling. Factors that may contribute to CNS signaling include life stress and abuse. Activation of IBS symptoms results from physiologic dysfunction that occurs peripherally (for example, motility disturbances or intestinal infection with inflammation). The peripheral stimuli send signals from the colon up the spinal cord to the thalamus and then to the brain via two pathways. The brain regions innervated by those pathways, which are activated in response to painful colorectal stimuli, include the somatosensory cortex—the area responsible for localization and intensity of peripheral sensations—and the limbic system, including the thalamus, insula, amygdala, and anterior cingulate cortex, which is linked to emotional stress and cognitive interpretation of pain. The brain has the ability to turn down the incoming signals through descending inhibitory pathways that modulate pain transmission and incoming signals are thus downregulated at the level of the spinal cord. As discussed earlier, CRH secretion and the HPA axis can also regulate inflammation, including that of the bowel mucosa. In IBS, however, the normal regulatory mechanisms of the brain-gut axis are dysfunctional, and there is impaired regulation of visceral pain (Naliboff et al. 2001) and altered HPA reactivity. The latter disrupts normal control of mucosal immune function that results in inflammation via cytokine activation (Dinan et al. 2006). With brain imaging, it can be shown that psychosocial difficulties (such as anxiety and life stress, including abuse or trauma, hypervigilance, and maladaptive coping) can impair those regulatory mechanisms (Drossman 2005). The presence and intensity of
OCR for page 66
Gulf War and Health, Volume 6: Physiologic, Psychologic, and Psychosocial Effects of Deployment-Related Stress symptoms depends on the degree of activity of the peripheral signals and how they are modulated by the CNS in the face of stress or other modifying factors. That model can be generalized to include other medical conditions. Most people with fibromyalgia, chronic fatigue, or other pain syndromes will have milder symptoms because their dysfunction is mostly peripheral, with little input from the CNS. But patients with more severe symptoms, greater symptom reporting, greater psychosocial disturbance, and poorer health status and quality of life will have greater CNS contributions to their symptoms. With increasing CNS dysregulation, the ability to filter incoming peripheral and visceral signals is impaired, and a person will report more symptoms (Chang et al. 2003; Clauw and Chrousos 1997; Sternberg 1995); this helps to explain the clinical similarity of those conditions when they are severe. CONCLUSIONS The stress response, the body’s reaction to stress, can be life-saving (and be adaptive) in the short term when a person confronts immediate stressors but can lead to illness or disease (and be maladaptive) in the long term when stressors are severe, recurrent, or persistent. In response to deployment-related stress, physiologic changes occur in the body, may persist for a long time after deployment has ended, and may result in symptoms and disorders that appear soon after exposure to the stressor or become evident only years later. Some biologic factors and life experiences can modify a person’s response to stress, including genes, early-life events, and the degree to which the stressor is perceived to be controllable. Those factors might help to explain the differences in people’s reactions to stress and the development of subsequent health effects. The studies discussed in this chapter provide a context for understanding why people deployed to a war zone may report more symptoms than people who are not deployed—the stress response results in a cascade of physiologic changes that can have profound effects on multiple organ systems. War-zone stressors might produce disruption in brain systems that mediate responses to stress and in central pain regulatory pathways that can result in greater reporting of physical and emotional symptoms. The continuation of altered physiologic states over months and years can contribute to the accumulation of a chronic stress burden that has adverse long-term health consequences. The possible long-term manifestations of those altered states in veterans are discussed in Chapters 5, 6, and 7. Much progress has been made in understanding the physiologic mechanisms of the stress response, particularly in animal models, but work remains to be done in human studies. Research on the effect of stressors on the endocrine, immune, cardiovascular, and gastrointestinal systems demonstrates the complexity of the interactions between those systems. REFERENCES Alheid GF, Heimer L. 1988. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: The striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience 27(1):1-39. Amat J, Baratta MV, Paul E, Bland ST, Watkins LR, Maier SF. 2005. Medial prefrontal cortex determined how stressor controllability affects behavior and dorsal raphe nucleus. Nature Neurosciences 8:365-371.
OCR for page 67
Gulf War and Health, Volume 6: Physiologic, Psychologic, and Psychosocial Effects of Deployment-Related Stress Anda RF, Williamson DF, Escobedo LG, Mast EE, Giovino GA, Remington PL. 1990. Depression and the dynamics of smoking. A national perspective. Journal of the American Medical Association 264(12):1541-1545. Barbara G, Stanghellini V, De Giorgio R, Corinaldesi R. 2006. Functional gastrointestinal disorders and mast cells: Implications for therapy. Neurogastroenterology and Motility 18(1):6-17. Barbara G, Wang B, Stanghellini V, de Giorgio R, Cremon C, Di Nardo G, Trevisani M, Campi B, Geppetti P, Tonini M, Bunnett NW, Grundy D, Corinaldesi R. 2007. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 132(1):26-37. Barr CS, Newman TK, Lindell S, Shannon C, Champoux M, Lesch KP, Suomi SJ, Goldman D, Higley JD. 2004. Interaction between serotonin transporter gene variation and rearing condition in alcohol preference and consumption in female primates. Archives of General Psychiatry 61(11):1146-1152. Black DW, Blum N, Letuchy E, Carney Doebbeling C, Forman-Hoffman VL, Doebbeling BN. 2006. Borderline personality disorder and traits in veterans: Psychiatric comorbidity, healthcare utilization, and quality of life along a continuum of severity. CNS Spectrums 11(9):680-689. Black PH, Garbutt LD. 2002. Stress, inflammation and cardiovascular disease. Journal of Psychosomatic Research 52(1):1-23. Bonne O, Grillon C, Vythilingam M, Neumeister A, Charney DS. 2004. Adaptive and maladaptive psychobiological responses to severe psychological stress: Implications for the discovery of novel pharmacotherapy. Neuroscience and Biobehavioral Reviews 28(1):65-94. Brady KT, Sinha R. 2005. Co-occurring mental and substance use disorders: The neurobiological effects of chronic stress. American Journal of Psychiatry 162(8):1483-1493. Brindley DN. 1995. Role of glucocorticoids and fatty acids in the impairment of lipid metabolism observed in the metabolic syndrome. International Journal of Obesity and Related Metabolic Disorders 19(Suppl 1):S69-S75. Carels RA, Szczepanski R, Blumenthal JA, Sherwood A. 1998. Blood pressure reactivity and marital distress in employed women. Psychosomatic Medicine 60(5):639-643. Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, Taylor A, Poulton R. 2002. Role of genotype in the cycle of violence in maltreated children. Science 297(5582):851-854. Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, Tie A, Wilson I. 2002. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 122(7):1778-1783. Chang L, Berman S, Mayer EA, Suyenobu B, Derbyshire S, Naliboff B, Vogt B, FitzGerald L, Mandelkern MA. 2003. Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia. American Journal of Gastroenterology 98(6):1354-1361. Charney DS. 2004. Psychobiological mechanisms of resilience and vulnerability: Implications for successful adaptation to extreme stress. American Journal of Psychiatry 161(2):195-216. Chourbaji S, Zacher C, Sanchis-Segura C, Dormann C, Vollmayr B, Gass P. 2005. Learned helplessness: Validity and reliability of depressive-like states in mice. Brain Research. Brain Research Protocols 16(1-3):70-78.
OCR for page 68
Gulf War and Health, Volume 6: Physiologic, Psychologic, and Psychosocial Effects of Deployment-Related Stress Chrousos GP, Gold PW. 1992. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. Journal of the American Medical Association 267(9):1244-1252. Clauw DJ, Chrousos GP. 1997. Chronic pain and fatigue syndromes: Overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 4(3):134-153. Cohen S, Tyrrell DA, Smith AP. 1991. Psychological stress and susceptibility to the common cold. New England Journal of Medicine 325(9):606-612. Coplan JD, Andrews MW, Rosenblum LA, Owens MJ, Friedman S, Gorman JM, Nemeroff CB. 1996. Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: Implications for the pathophysiology of mood and anxiety disorders. Proceedings of the National Academy of Sciences of the United States of America 93(4):1619-1623. Dallman MF, Pecoraro N, Akana SF, La Fleur SE, Gomez F, Houshyar H, Bell ME, Bhatnagar S, Laugero KD, Manalo S. 2003. Chronic stress and obesity: A new view of “comfort food.” Proceedings of the National Academy of Sciences of the United States of America 100(20):11696-11701. Danese A, Pariante CM, Caspi A, Taylor A, Poulton R. 2007. Childhood maltreatment predicts adult inflammation in a life-course study. Proceedings of the National Academy of Sciences of the United States of America 104(4):1319-1324. Davis M, Whalen PJ. 2001. The amygdala: Vigilance and emotion. Molecular Psychiatry 6(1):13-34. Dhabhar FS. 2000. Acute stress enhances while chronic stress suppresses skin immunity. The role of stress hormones and leukocyte trafficking. Annals of the New York Academy of Sciences 917:876-893. Dhabhar FS, McEwen BS. 1999. Enhancing versus suppressive effects of stress hormones on skin immune function. Proceedings of the National Academy of Sciences of the United States of America 96(3):1059-1064. Dilley J, Jones M, Drossman D. 2005. Understanding the mind-body connection in the functional GI disorders: Anatomic and physiologic relationships between the central nervous system and digestive tract. In: Jones M, Crowell M, editors. Contemporary Diagnosis and Management of Functional Digestive Disorders. 1st Ed. Newton, PA: Handbooks in Health Care. Dinan TG, Quigley EM, Ahmed SM, Scully P, O’Brien S, O’Mahony L, O’Mahony S, Shanahan F, Keeling PW. 2006. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: Plasma cytokines as a potential biomarker? Gastroenterology 130(2):304-311. Drossman DA. 2005. Brain imaging and its implications for studying centrally targeted treatments in irritable bowel syndrome: A primer for gastroenterologists. Gut 54(5):569-573. Drossman DA, Ringel Y, Vogt BA, Leserman J, Lin W, Smith JK, Whitehead W. 2003. Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome. Gastroenterology 124(3):754-761. Dube SR, Anda RF, Felitti VJ, Edwards VJ, Croft JB. 2002. Adverse childhood experiences and personal alcohol abuse as an adult. Addictive Behaviors 27(5):713-725.
OCR for page 69
Gulf War and Health, Volume 6: Physiologic, Psychologic, and Psychosocial Effects of Deployment-Related Stress Eisch AJ, Harburg GC. 2006. Opiates, psychostimulants, and adult hippocampal neurogenesis: Insights for addiction and stem cell biology. Hippocampus 16(3):271-286. Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP. 2005. Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 12(5):255-269. Ewart CK, Taylor CB, Kraemer HC, Agras WS. 1991. High blood pressure and marital discord: Not being nasty matters more than being nice. Health Psychology 10(3):155-163. Fukudo S, Nomura T, Hongo M. 1998. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut 42(6):845-849. Glaser R, Rabin B, Chesney M, Cohen S, Natelson B. 1999. Stress-induced immunomodulation: Implications for infectious diseases? Journal of the American Medical Association 281(24):2268-2670. Glaser R, Sheridan J, Malarkey WB, MacCallum RC, Kiecolt-Glaser JK. 2000. Chronic stress modulates the immune response to a pneumococcal pneumonia vaccine. Psychosomatic Medicine 62(6):804-807. Gold PE, Van Buskirk RB. 1975. Facilitation of time-dependent memory processes with posttrial epinephrine injections. Behavioral Biology 13(2):145-153. Graham JE, Robles TF, Kiecolt-Glaser JK, Malarkey WB, Bissell MG, Glaser R. 2006. Hostility and pain are related to inflammation in older adults. Brain, Behavior, and Immunity 20(4):389-400. Greaves DR, Channon KM. 2002. Inflammation and immune responses in atherosclerosis. Trends in Immunology 23(11):535-541. Hariri AR, Drabant EM, Weinberger DR. 2006. Imaging genetics: Perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing. Biological Psychiatry 59(10):888-897. Harlow H. 1974. Learning to Love. New York: Jason Aronson. Herman JP, Schafer MK, Young EA, Thompson R, Douglass J, Akil H, Watson SJ. 1989. Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis. Journal of Neuroscience 9(9):3072-3082. Ichise M, Vines DC, Gura T, Anderson GM, Suomi SJ, Higley JD, Innis RB. 2006. Effects of early life stress on [11C] DASB positron emission tomography imaging of serotonin transporters in adolescent peer- and mother-reared rhesus monkeys. Journal of Neuroscience 26(17):4638-4643. Judd AM, Call GB, Barney M, McIlmoil CJ, Balls AG, Adams A, Oliveira GK. 2000. Possible function of IL-6 and TNF as intraadrenal factors in the regulation of adrenal steroid secretion. Annals of the New York Academy of Sciences 917:628-637. Kardys I, Knetsch AM, Bleumink GS, Deckers JW, Hofman A, Stricker BH, Witteman JC. 2006. C-reactive protein and risk of heart failure. The Rotterdam Study. American Heart Journal 152(3):514-520. Kempermann G, Neumann H. 2003. Neuroscience. Microglia: The enemy within? Science 302(5651):1689-1690.
OCR for page 70
Gulf War and Health, Volume 6: Physiologic, Psychologic, and Psychosocial Effects of Deployment-Related Stress Kiecolt-Glaser JK, Malarkey WB, Chee M, Newton T, Cacioppo JT, Mao HY, Glaser R. 1993. Negative behavior during marital conflict is associated with immunological down-regulation. Psychosomatic Medicine 55(5):395-409. Kiecolt-Glaser JK, Marucha PT, Malarkey WB, Mercado AM, Glaser R. 1995. Slowing of wound healing by psychological stress. Lancet 346(8984):1194-1196. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R. 2003. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proceedings of the National Academy of Sciences of the United States of America 100(15):9090-9095. Kiecolt-Glaser JK, Loving TJ, Stowell JR, Malarkey WB, Lemeshow S, Dickinson SL, Glaser R. 2005. Hostile marital interactions, proinflammatory cytokine production, and wound healing. Archives of General Psychiatry 62(12):1377-1384. Levine S. 1962. Plasma-free corticosteroid response to electric shock in rats stimulated in infancy. Science 135:795-796. Libby P. 2002. Inflammation in atherosclerosis. Nature 420(6917):868-874. Liston C, Miller MM, Goldwater DS, Radley JJ, Rocher AB, Hof PR, Morrison JH, McEwen BS. 2006. Stress-induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual attentional set-shifting. Journal of Neuroscience 26(30):7870-7874. Liu D, Diorio J, Tannenbaum B, Caldji C, Francis D, Freedman A, Sharma S, Pearson D, Plotsky PM, Meaney MJ. 1997. Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 277(5332):1659-1662. Longstreth G, Thompson W, Chey W, Houghton L, Mearin F, Spiller R. 2006. Functional bowel disorders. In: Drossman D, Corazziari E, Delvaux M, Spiller R, Talley N, Thompson W, editors. Rome III: The Functional Gastrointestinal Disorders. 3rd Ed. McLean, VA: Degnon Associates, Inc. MacPherson A, Dinkel K, Sapolsky R. 2005. Glucocorticoids worsen excitotoxin-induced expression of pro-inflammatory cytokines in hippocampal cultures. Experimental Neurology 194(2):376-383. Maggio M, Guralnik JM, Longo DL, Ferrucci L. 2006. Interleukin-6 in aging and chronic disease: a magnificent pathway. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 61(6):575-584. Maier SF, Watkins LR. 1998. Stressor controllability, anxiety and serotonin. Cognitive Therapy and Research 22(6):595-613. Maier SF, Watkins LR. 2005. Stressor controllability and learned helplessness: The roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neuroscience and Biobehavioral Reviews 29(4-5):829-841. Maier SF, Seligman MEP, Solomon RL. 1969. Pavlovian fear conditioning and learned helplessness. In: Campbell BA, Church RM, editors. Punishment. New York: Appleton-Century-Crofts. Maier SF, Busch CR, Maswood S, Grahn RE, Watkins LR. 1995. The dorsal raphe nucleus is a site of action mediating the behavioral effects of the benzodiazepine receptor inverse agonist DMCM. Behavioral Neuroscience 109(4):759-766.
OCR for page 71
Gulf War and Health, Volume 6: Physiologic, Psychologic, and Psychosocial Effects of Deployment-Related Stress Malarkey WB, Mills PJ. 2007. Endocrinology: The active partner in PNI research. Brain, Behavior, and Immunity 21(2):161-168. Mathew SJ, Coplan JD, Smith EL, Scharf BA, Owens MJ, Nemeroff CB, Mann JJ, Gorman JM, Rosenblum LA. 2002. Cerebrospinal fluid concentrations of biogenic amines and corticotropin-releasing factor in adolescent non-human primates as a function of the timing of adverse early rearing. Stress 5(3):185-193. McDougall SJ, Widdop RE, Lawrence AJ. 2004. Medial prefrontal cortical integration of psychological stress in rats. The European Journal of Neuroscience 20(9):2430-2440. McEwen B, Lasley E. 2002. The End of Stress as We Know It. Washington, DC: Joseph Henry Press. McEwen BS. 1998. Protective and damaging effects of stress mediators. New England Journal of Medicine 338(3):171-179. McEwen BS. 1999a. Stress and hippocampal plasticity. Annual Review of Neuroscience 22:105-122. McEwen BS. 1999b. Stress and the aging hippocampus. Frontiers in Neuroendocrinology 20(1):49-70. McEwen BS. 2002a. The neurobiology and neuroendocrinology of stress. Implications for posttraumatic stress disorder from a basic science perspective. The Psychiatric Clinics of North America 25(2):469-494, ix. McEwen BS. 2002b. Sex, stress and the hippocampus: Allostasis, allostatic load and the aging process. Neurobiology of Aging 23(5):921-939. McEwen BS. 2005. Stressed or stressed out: What is the difference? The Journal of Neuropsychiatry and Clinical Neurosciences 30(5):315-318. McEwen BS. 2006. Sleep deprivation as a neurobiologic and physiologic stressor: Allostasis and allostatic load. Metabolism 55(10 Suppl 2):S20-S23. McEwen BS. 2007. Physiology and neurobiology of stress and adaptation: Central role of the brain. Physiological Reviews 87(3):873-904. McEwen BS, Wingfield JC. 2003. The concept of allostasis in biology and biomedicine. Hormones and Behavior 43(1):2-15. McEwen BS, Weiss JM, Schwartz LS. 1968. Selective retention of corticosterone by limbic structures in rat brain. Nature 220(5170):911-912. McEwen BS, Gould EA, Sakai RR. 1992. The vulnerability of the hippocampus to protective and destructive effects of glucocorticoids in relation to stress. The British Journal of Psychiatry. (Suppl 15):18-23. McGaugh J, Introini-Collison I, Cahill L, Kim M, Liang K. 1992. Involvement of the amygdala in neuromodulatory influences on memory storage. In: Aggleton J, editor. The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction. New York: Wiley-Liss. Pp. 431-451. Meaney MJ, Aitken DH, Bodnoff SR, Iny LJ, Tatarewicz JE, Sapolsky RM. 1985. Early postnatal handling alters glucocorticoid receptor concentrations in selected brain regions. Behavioral Neuroscience 99(4):765-770.
OCR for page 72
Gulf War and Health, Volume 6: Physiologic, Psychologic, and Psychosocial Effects of Deployment-Related Stress Meaney MJ, Aitken DH, van Berkel C, Bhatnagar S, Sapolsky RM. 1988. Effect of neonatal handling on age-related impairments associated with the hippocampus. Science 239(4841 Pt 1):766-768. Mineka S, Suomi SJ. 1978. Social separation in monkeys. Psychological Bulletin 85(6):1376-1400. Mirescu C, Gould E. 2006. Stress and adult neurogenesis. Hippocampus 16(3):233-238. Monje ML, Toda H, Palmer TD. 2003. Inflammatory blockade restores adult hippocampal neurogenesis. Science 302(5651):1760-1765. Naliboff BD, Derbyshire SW, Munakata J, Berman S, Mandelkern M, Chang L, Mayer EA. 2001. Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosomatic Medicine 63(3):365-375. Overmier JB, Seligman ME. 1967. Effects of inescapable shock upon subsequent escape and avoidance responding. Journal of Comparative and Physiological Psychology 63(1):28-33. Pfaff DW. 2005. Brain Arousal and the Information Theory: Neural and Genetic Mechanisms. Boston, MA: Harvard University Press. Pham K, Nacher J, Hof PR, McEwen BS. 2003. Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus. The European Journal of Neuroscience 17(4):879-886. Pickering TG. 2004. Reflections in hypertension: Work and blood pressure. Journal of Clinical Hypertension (Greenwich, Conn) 6(7):403-405. Radley JJ, Morrison JH. 2005. Repeated stress and structural plasticity in the brain. Ageing Research Reviews 4(2):271-287. Radley JJ, Arias CM, Sawchenko PE. 2006. Regional differentiation of the medial prefrontal cortex in regulating adaptive responses to acute emotional stress. Journal of Neuroscience 26(50):12967-12976. Reaven G, Abbasi F, McLaughlin T. 2004. Obesity, insulin resistance, and cardiovascular disease. Recent Progress in Hormone Research 59:207-223. Reiche EM, Nunes SO, Morimoto HK. 2004. Stress, depression, the immune system, and cancer. The Lancet Oncology 5(10):617-625. Ringel Y, Drossman DA, Turkington TG, Bradshaw B, Hawk TC, Bangdiwala S, Coleman RE, Whitehead WE. 2003a. Regional brain activation in response to rectal distension in patients with irritable bowel syndrome and the effect of a history of abuse. Digestive Diseases and Sciences 48(9):1774-1781. Ringel Y, Drossman D, Leserman J, Lin W, Liu H, Vogt B, Whitehead W. 2003b. Association of anterior cingulate cortex (ACC) activation with psychosocial distress and pain reports. Gastroenterology 124(4):A-97. Roozendaal B, Okuda S, de Quervain DJ, McGaugh JL. 2006. Glucocorticoids interact with emotion-induced noradrenergic activation in influencing different memory functions. Neuroscience 138(3):901-910. Rosmond R, Lapidus L, Marin P, Bjorntorp P. 1996. Mental distress, obesity and body fat distribution in middle-aged men. Obesity Research 4(3):245-252.
OCR for page 73
Gulf War and Health, Volume 6: Physiologic, Psychologic, and Psychosocial Effects of Deployment-Related Stress Rozanski A, Blumenthal JA, Kaplan J. 1999. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 99(16):2192-2217. Sagami Y, Shimada Y, Tayama J, Nomura T, Satake M, Endo Y, Shoji T, Karahashi K, Hongo M, Fukudo S. 2004. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut 53(7):958-964. Sapolsky RM. 2003. Stress and plasticity in the limbic system. Neurochemical Research 28(11):1735-1742. Sapolsky RM, Krey LC, McEwen BS. 1986. The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis. Endocrine Reviews 7(3):284-301. Seligman ME, Maier SF. 1967. Failure to escape traumatic shock. Journal of Experimental Psychology 74(1):1-9. Selye H. 1956. The Stress of Life. New York: McGraw-Hill. Shin LM, Orr SP, Carson MA, Rauch SL, Macklin ML, Lasko NB, Peters PM, Metzger LJ, Dougherty DD, Cannistraro PA, Alpert NM, Fischman AJ, Pitman RK. 2004. Regional cerebral blood flow in the amygdala and medial prefrontal cortex during traumatic imagery in male and female Vietnam veterans with PTSD. Archives of General Psychiatry 61(2):168-176. Shumyatsky GP, Malleret G, Shin RM, Takizawa S, Tully K, Tsvetkov E, Zakharenko SS, Joseph J, Vronskaya S, Yin D, Schubart UK, Kandel ER, Bolshakov VY. 2005. Stathmin, a gene enriched in the amygdala, controls both learned and innate fear. Cell 123(4):697-709. Soderholm JD, Yang PC, Ceponis P, Vohra A, Riddell R, Sherman PM, Perdue MH. 2002. Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. Gastroenterology 123(4):1099-1108. Spiegel K, Tasali E, Penev P, Van Cauter E. 2004. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Annals of Internal Medicine 141(11):846-850. Steptoe A, Siegrist J, Kirschbaum C, Marmot M. 2004. Effort-reward imbalance, overcommitment, and measures of cortisol and blood pressure over the working day. Psychosomatic Medicine 66(3):323-329. Sternberg EM. 1995. Neuroendocrine factors in susceptibility to inflammatory disease: Focus on the hypothalamic-pituitary-adrenal axis. Hormone Research 43(4):159-161. Tache Y, Million M, Nelson AG, Lamy C, Wang L. 2005. Role of corticotropin-releasing factor pathways in stress-related alterations of colonic motor function and viscerosensibility in female rodents. Gender Medicine 2(3):146-154. Taheri S, Lin L, Austin D, Young T, Mignot E. 2004. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Medicine 1(3):e62. Teel CS, Press AN. 1999. Fatigue among elders in caregiving and noncaregiving roles. West Journal of Nursing Research 21(4):498-514; discussion 514-520. Thayer JF, Brosschot JF. 2005. Psychosomatics and psychopathology: Looking up and down from the brain. Psychoneuroendocrinology 30(10):1050-1058.
OCR for page 74
Gulf War and Health, Volume 6: Physiologic, Psychologic, and Psychosocial Effects of Deployment-Related Stress Timio M, Saronio P, Verdura C, Schiaroli M, Timio F, Monarca C. 2001. A link between psychosocial factors and blood pressure trend in women. Physiology and Behavior 73(3):359-363. Tracey KJ. 2002. The inflammatory reflex. Nature 420(6917):853-859. Vermetten E, Bremner JD. 2002. Circuits and systems in stress. II. Applications to neurobiology and treatment in posttraumatic stress disorder. Depression and Anxiety 16(1):14-38. Viswanathan K, Dhabhar FS. 2005. Stress-induced enhancement of leukocyte trafficking into sites of surgery or immune activation. Proceedings of the National Academy of Sciences of the United States of America 102(16):5808-5813. Vollmayr B, Henn FA. 2001. Learned helplessness in the rat: Improvements in validity and reliability. Brain Research. Brain Research Protocols 8(1):1-7. Vyas A, Mitra R, Shankaranarayana Rao BS, Chattarji S. 2002. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. Journal of Neuroscience 22(15):6810-6818. Weiss JM. 1968. Effects of coping responses on stress. Journal of Comparative and Physiological Psychology 65(2):251-260. Weiss JM, Goodman PA, Losito BG, Corrigan SA, Charry JM, Bailey WH. 1981. Behavioral depression produced by an uncontrollable stressor: Relationship to norepinephrine, dopamine, and serotonin levels in various regions of the rat brain. Brain Research Reviews 3:167-205. Wessely S, Hotopf M, Sharpe M. 1998. Chronic Fatigue and Its Syndromes. New York: Oxford University Press. Will MJ, Watkins LR, Maier SF. 1998. Uncontrollable stress potentiates morphine’s rewarding properties. Pharmacology, Biochemistry, and Behavior 60(3):655-664. Wu H, Devi R, Malarkey WB. 1996. Localization of growth hormone messenger ribonucleic acid in the human immune system—a Clinical Research Center study. The Journal of Clinical Endocrinology and Metabolism 81(3):1278-1282. Yang PC, Jury J, Soderholm JD, Sherman PM, McKay DM, Perdue MH. 2006. Chronic psychological stress in rats induces intestinal sensitization to luminal antigens. American Journal of Pathology 168(1):104-114.